AI supercomputer being used to develop vaccines for Alzheimer's

One of the UK's most powerful supercomputers, iSambard-AI, has begun using artificial intelligence to develop vaccines and new drugs for rare diseases. Scientists mainly apply it to research and develop vaccines for Alzheimer's disease, other forms of dementia or various types of cancer. The computer should be fully operational this summer.

AI supercomputer being used to develop vaccines for Alzheimer's

Waste energy from the supercomputer could one day heat nearby homes in north Bristol.

UK’s AI supercomputer to transform drug development

A groundbreaking £225 million supercomputer, Isambard-AI, is set to revolutionize the medical field by aiding in the development of new drugs and vaccines using artificial intelligence. Situated in Bristol, this state-of-the-art facility will become the most potent supercomputer in the UK when it becomes fully operational this summer. Prime Minister Sir Keir Starmer recently announced… Source

The team is using the computer to develop vaccines for Alzheimer's and other forms of dementia, as well as treatments for heart disease, emphysema and various types of cancer. The technology is even being used by a group of researchers to vastly improve the detection of a type of skin cancer called melanoma. Sir Keir Starmer has revealed plans to "unleash Artificial Intelligence" in the UK. A £225 million supercomputer is using Artificial Intell…

University of Strathclyde-led study to explore AI’s role in accelerating vaccine and medicine development

A new study led by the University of Strathclyde will investigate how artificial intelligence (AI) and machine learning could expedite the development and production of mRNA-based vaccines and medicines. The initiative has received funding of over £440,000 from Innovate UK to explore faster processes in genomic medicine—analysing DNA to understand genetic makeup for treating cancer, rare diseases, or producing new vaccines. The study will focus …